Cargando…

LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma

Malignant astroctyoma and glioblastoma are diffuse CNS tumors that have markedly similar features, including microvascular proliferation and necrosis, and the latter presents higher grade and poorer survival. The Isocitrate dehydrogenase 1/2 (IDH) mutation further predicts improved survival and is p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglas, Christopher, Lomeli, Naomi, Vu, Thao, Pham, James, Bota, Daniela A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153221/ https://www.ncbi.nlm.nih.gov/pubmed/37131765 http://dx.doi.org/10.1101/2023.04.13.536817

Ejemplares similares

Discovery and Validation of Novel LonP1 and Proteasome Inhibitor in IDH1-R132H Malignant Astrocytoma Models
por: Douglas, Christopher, et al.
Publicado: (2023)

BSCI-03 THE ROLE OF LONP1 IN DRIVING ENHANCED PMT IN THE ‘LEADING EDGE’ NICHE IN GLIOBLASTOMA
por: Douglas, Christopher, et al.
Publicado: (2022)

Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma
por: Di, Kaijun, et al.
Publicado: (2016)

LonP1 Links Mitochondria–ER Interaction to Regulate Heart Function
por: Li, Yujie, et al.
Publicado: (2023)

Defective mitochondrial protease LonP1 can cause classical mitochondrial disease
por: Peter, Bradley, et al.
Publicado: (2018)

The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma
por: Maneix, Laure, et al.
Publicado: (2021)

Roles of LonP1 in Oral-Maxillofacial Developmental Defects and Tumors: A Novel Insight
por: Ma, Haozhen, et al.
Publicado: (2022)

AKT PHOSPHORYLATION OF MITOCHONDRIAL LonP1 PROTEASE ENABLES OXIDATIVE METABOLISM AND ADVANCED TUMOR TRAITS
por: Ghosh, Jagadish C., et al.
Publicado: (2019)

IDH-1(R132H) mutation status in diffuse glioma patients: implications for classification
por: Wang, Peng-fei, et al.
Publicado: (2016)

LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells
por: Gibellini, Lara, et al.
Publicado: (2018)

Lon Peptidase 2, Peroxisomal (LONP2) Contributes to Cervical Carcinogenesis via Oxidative Stress
por: Wu, Wangrong, et al.
Publicado: (2018)

Inhibition of mitochondrial LonP1 protease by allosteric blockade of ATP binding and hydrolysis via CDDO and its derivatives
por: Lee, Jae, et al.
Publicado: (2022)

Global Proteome of LonP1(+/−) Mouse Embryonal Fibroblasts Reveals Impact on Respiratory Chain, but No Interdependence between Eral1 and Mitoribosomes
por: Key, Jana, et al.
Publicado: (2019)

Mitochondrial LonP1 protease is implicated in the degradation of unstable Parkinson's disease-associated DJ-1/PARK 7 missense mutants
por: Sánchez-Lanzas, Raúl, et al.
Publicado: (2021)

NEK5 interacts with LonP1 and its kinase activity is essential for the regulation of mitochondrial functions and mtDNA maintenance
por: Ferezin, Camila de Castro, et al.
Publicado: (2021)

Characterization of an IDH1 R132H Rabbit Monoclonal Antibody, MRQ-67, and Its Applications in the Identification of Diffuse Gliomas
por: Copaciu, Raul, et al.
Publicado: (2023)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition
por: Sears, Thomas K., et al.
Publicado: (2022)

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
por: Tesileanu, C. Mircea S., et al.
Publicado: (2021)

IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway
por: Li, Kaishu, et al.
Publicado: (2017)

The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas
por: Cooper, Lee A. D., et al.
Publicado: (2010)

Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma
por: Ding, Bi-Sen, et al.
Publicado: (2013)

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
por: Pellegatta, Serena, et al.
Publicado: (2015)

Evidence for mitochondrial Lonp1 expression in the nucleus
por: Gibellini, Lara, et al.
Publicado: (2022)

Nanomechanical Signatures in Glioma Cells Depend on CD44 Distribution in IDH1 Wild-Type but Not in IDH1R132H Mutant Early-Passage Cultures
por: Shmelev, Mikhail E., et al.
Publicado: (2023)

The prognostic IDH1(R132) mutation is associated with reduced NADP(+)-dependent IDH activity in glioblastoma
por: Bleeker, Fonnet E., et al.
Publicado: (2010)

IDH1(R132H) Mutation Increases U87 Glioma Cell Sensitivity to Radiation Therapy in Hypoxia
por: Wang, Xiao-Wei, et al.
Publicado: (2014)

The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas
por: Dénes, Anna, et al.
Publicado: (2023)

Differential Expression of Lonp1 Isoforms in Cancer Cells
por: Zanini, Giada, et al.
Publicado: (2022)

HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma
por: Garrett, Matthew C., et al.
Publicado: (2023)

Generation of induced neural stem cells with inducible IDH1(R132H) for analysis of glioma development and drug testing
por: Rosiak-Stec, Kamila, et al.
Publicado: (2020)

IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR
por: Yin, Narui, et al.
Publicado: (2020)

High EZH2 Protein Expression Is a Poor Prognostic Predictor in IDH1 R132H-Negative Gliomas
por: Wong, Yin Ping, et al.
Publicado: (2022)

Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells
por: Chandran, Uma R., et al.
Publicado: (2015)

Evaluation of gliomas peritumoral diffusion and prediction of IDH1 mutation by IVIM-DWI
por: Gu, Taifu, et al.
Publicado: (2021)

Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment
por: Trautwein, Christoph, et al.
Publicado: (2022)

NGMA-1. Quantification of IDH mutant alleles predicts outcome in diffuse gliomas
por: Voisin, Mathew, et al.
Publicado: (2021)

Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells
por: Adnani, Lata, et al.
Publicado: (2022)

IDH1(R132H) decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a
por: NIE, QUAN-MIN, et al.
Publicado: (2015)

Impaired Mitochondrial Morphology and Functionality in Lonp1(wt/−) Mice
por: De Gaetano, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mrmgdesuds7d4ma519g3poi5rs